AstraZeneca’s Imfinzi prolongs survival in aggressive lung cancer

FRANKFURT: AstraZeneca ‘s cancer treatment Imfinzi has been shown to prolong survival in a particularly aggressive type of lung cancer by close to three months, as the British drugmaker holds its ground in a crowded field against rival immunotherapy drugs. Imfinzi, when combined with chemotherapy , resulted in a […]

Leave a Reply